Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

TO THE EDITOR:

  • 123456 Profile photo of Madelyn

    in a retrospective review of 133 patients treated with polaBR for relapsed / refractory DLBCL showed a 57% ORR and a 31% CR rate, median PFS was 4.8 months and median OS was 8.2 months.